메뉴 건너뛰기




Volumn 40, Issue 8, 1996, Pages 1806-1810

Evaluation of renal toxicity and antifungal activity of free and liposomal amphotericin b following a single intravenous dose to diabetic rats with systemic candidiasis

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; AMPHOTERICIN B DEOXYCHOLATE; INULIN;

EID: 0029795939     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.40.8.1806     Document Type: Article
Times cited : (16)

References (30)
  • 1
    • 0024475254 scopus 로고
    • Pharmacokinetics and toxicity of continuous infusion of amphotericin B in cancer patients
    • Cabor, G. G., R. Pazdur, F. A. Valeriote, and L. H. H. Baker. 1989. Pharmacokinetics and toxicity of continuous infusion of amphotericin B in cancer patients. J. Pharm. Sci. 78:307-310.
    • (1989) J. Pharm. Sci. , vol.78 , pp. 307-310
    • Cabor, G.G.1    Pazdur, R.2    Valeriote, F.A.3    Baker, L.H.H.4
  • 2
    • 9444294262 scopus 로고
    • Clinical application of therapeutic drug monitoring
    • W. J. Taylor and M. H. Diers Caviness (ed.), Diagnostics Division, Abbott Laboratories, Irving, Tex.
    • Cipolle, R. J., and J. S. Solomkin. 1986. Clinical application of therapeutic drug monitoring, p. 321-328. In W. J. Taylor and M. H. Diers Caviness (ed.), Amphotericin B. Diagnostics Division, Abbott Laboratories, Irving, Tex.
    • (1986) Amphotericin B , pp. 321-328
    • Cipolle, R.J.1    Solomkin, J.S.2
  • 3
    • 0027167664 scopus 로고
    • The hypertriglyceridemia of acquired immunodeficiency syndrome is associated with an increased prevalence of low density lipoprotein subclass pattern B
    • Feingold, K. R., R. M. Krauss, M. Pang, W. Doerrler, P. Jensen, and C. Grunfield. 1993. The hypertriglyceridemia of acquired immunodeficiency syndrome is associated with an increased prevalence of low density lipoprotein subclass pattern B. J. Clin. Endocrinol. Metab. 76:1423-1427.
    • (1993) J. Clin. Endocrinol. Metab. , vol.76 , pp. 1423-1427
    • Feingold, K.R.1    Krauss, R.M.2    Pang, M.3    Doerrler, W.4    Jensen, P.5    Grunfield, C.6
  • 5
    • 0026716993 scopus 로고
    • Lipids, lipoproteins, triglyceride clearance, and cytokines in human immunodeficiency virus infection and the acquired immunodeficiency syndrome
    • Grunfeld, C., M. Pang, W. Doerrler, J. K. Shigenaga, P. Jensen, and K. R. Feingold. 1992. Lipids, lipoproteins, triglyceride clearance, and cytokines in human immunodeficiency virus infection and the acquired immunodeficiency syndrome. J. Clin. Endocrinol. Metab. 74:1045-1052.
    • (1992) J. Clin. Endocrinol. Metab. , vol.74 , pp. 1045-1052
    • Grunfeld, C.1    Pang, M.2    Doerrler, W.3    Shigenaga, J.K.4    Jensen, P.5    Feingold, K.R.6
  • 6
    • 0002819939 scopus 로고
    • Study of lipids and lipoproteins
    • A. M. Scanu and A. A. Spector (ed.), Marcel Dekker, Inc., New York
    • Harmony, J. A. K., A. L. Aleson, and B. M. McCarthy. 1986. Study of lipids and lipoproteins, p. 403-430. In A. M. Scanu and A. A. Spector (ed.), Biochemistry and biology of plasma lipoproteins. Marcel Dekker, Inc., New York.
    • (1986) Biochemistry and Biology of Plasma Lipoproteins , pp. 403-430
    • Harmony, J.A.K.1    Aleson, A.L.2    McCarthy, B.M.3
  • 7
    • 0001571784 scopus 로고
    • Unusual lipid structures selectively reduce the toxicity of amphotericin B
    • Janoff, A. S., L. T. Boni, M. C. Popescu, et al. 1988. Unusual lipid structures selectively reduce the toxicity of amphotericin B. Proc. Natl. Acad. Sci. USA 85:6122-6128.
    • (1988) Proc. Natl. Acad. Sci. USA , vol.85 , pp. 6122-6128
    • Janoff, A.S.1    Boni, L.T.2    Popescu, M.C.3
  • 8
    • 0023804373 scopus 로고
    • Lipid and lipoprotein abnormalities in diabetic patients with peripheral vascular disease
    • Laakso, M., and K. Pyorala. 1988. Lipid and lipoprotein abnormalities in diabetic patients with peripheral vascular disease. Atherosclerosis 74:55-63.
    • (1988) Atherosclerosis , vol.74 , pp. 55-63
    • Laakso, M.1    Pyorala, K.2
  • 9
    • 0024162404 scopus 로고
    • Liposomes as carriers of antifungal drugs
    • Lopez-Berestein, G. 1988. Liposomes as carriers of antifungal drugs. Ann. N. Y. Acad. Sci. 544:590-597.
    • (1988) Ann. N. Y. Acad. Sci. , vol.544 , pp. 590-597
    • Lopez-Berestein, G.1
  • 11
    • 0021958862 scopus 로고
    • Liposomal-amphotericin B for the treatment of systemic fungal infections in patients with cancer: A preliminary study
    • Lopez-Berestein, G., V. Fainstein, R. L. Hopfer, et al. 1985. Liposomal-amphotericin B for the treatment of systemic fungal infections in patients with cancer: a preliminary study. J. Infect. Dis. 154:704-710.
    • (1985) J. Infect. Dis. , vol.154 , pp. 704-710
    • Lopez-Berestein, G.1    Fainstein, V.2    Hopfer, R.L.3
  • 12
    • 0021268461 scopus 로고
    • Liposome-encapsulated amphotericin B for the treatment of disseminated candidiasis in neutropenic mice
    • Lopez-Berestein, G., R. L. Hopfer, R. Mehta, K. Mehta, E. M. Hersh, and R. L. Juliano. 1984. Liposome-encapsulated amphotericin B for the treatment of disseminated candidiasis in neutropenic mice. J. Infect. Dis. 150: 278-283.
    • (1984) J. Infect. Dis. , vol.150 , pp. 278-283
    • Lopez-Berestein, G.1    Hopfer, R.L.2    Mehta, R.3    Mehta, K.4    Hersh, E.M.5    Juliano, R.L.6
  • 15
    • 0021709937 scopus 로고
    • Altered tissue distribution of amphotericin B by liposomal encapsulation; comparison of normal mice to mice infected with Candida albicans
    • Lopez-Berestein, G., M. G. Rosenblum, and R. Mehta. 1984. Altered tissue distribution of amphotericin B by liposomal encapsulation; comparison of normal mice to mice infected with Candida albicans. Cancer Drug Delivery 1:199-205.
    • (1984) Cancer Drug Delivery , vol.1 , pp. 199-205
    • Lopez-Berestein, G.1    Rosenblum, M.G.2    Mehta, R.3
  • 18
    • 0028337222 scopus 로고
    • Phagocyte transport as a mechanism for enhanced therapeutic activity of liposomal amphotericin B
    • Mehta, R. T., T. J. McQueen, A. Keyhani, and G. Lopez-Berestein. 1994. Phagocyte transport as a mechanism for enhanced therapeutic activity of liposomal amphotericin B. Exp. Chemother. 40:256-264.
    • (1994) Exp. Chemother. , vol.40 , pp. 256-264
    • Mehta, R.T.1    McQueen, T.J.2    Keyhani, A.3    Lopez-Berestein, G.4
  • 19
    • 0025298008 scopus 로고
    • Interaction of lipid transfer protein with plasma lipoproteins and cell membranes
    • Morton, R. E. 1990. Interaction of lipid transfer protein with plasma lipoproteins and cell membranes. Experientia 46:552-560.
    • (1990) Experientia , vol.46 , pp. 552-560
    • Morton, R.E.1
  • 20
    • 0020573284 scopus 로고
    • Inter-relationship of lipids transferred by the lipid-transfer protein isolated from human lipoprotein-deficient plasma
    • Morton, R. E., and D. B. Zilversmit. 1983. Inter-relationship of lipids transferred by the lipid-transfer protein isolated from human lipoprotein-deficient plasma. J. Biol. Chem. 258:11751-11757.
    • (1983) J. Biol. Chem. , vol.258 , pp. 11751-11757
    • Morton, R.E.1    Zilversmit, D.B.2
  • 21
    • 0028321467 scopus 로고
    • Amphotericin B use in a major acute care hospital
    • Nicholl, T., P. Phillips, and P. J. Jewesson. 1994. Amphotericin B use in a major acute care hospital. Clin. Ther. 16:28-40.
    • (1994) Clin. Ther. , vol.16 , pp. 28-40
    • Nicholl, T.1    Phillips, P.2    Jewesson, P.J.3
  • 22
    • 0023906502 scopus 로고
    • Adverse effect of amphotericin B administration on renal hemodynamics in the rat neurohumoral mechanisms and influence of calcium channel blocker
    • Tolins, J. P., and L. Raij. 1989. Adverse effect of amphotericin B administration on renal hemodynamics in the rat neurohumoral mechanisms and influence of calcium channel blocker. J. Pharmacol. Exp. Ther. 245:594-599.
    • (1989) J. Pharmacol. Exp. Ther. , vol.245 , pp. 594-599
    • Tolins, J.P.1    Raij, L.2
  • 23
    • 0025220388 scopus 로고
    • Pharmacokinetics of two alternative dosage forms for cyclosporine: Liposomes and intralipid
    • Venkataram, S., W. M. Awni, K. Jordan, and Y. E. Rahman. 1990. Pharmacokinetics of two alternative dosage forms for cyclosporine: liposomes and intralipid. J. Pharm. Sci. 79:216-219.
    • (1990) J. Pharm. Sci. , vol.79 , pp. 216-219
    • Venkataram, S.1    Awni, W.M.2    Jordan, K.3    Rahman, Y.E.4
  • 24
    • 0027513337 scopus 로고
    • Role of liposome composition and temperature on the distribution of amphotericin B in serum lipoproteins
    • Wasan, K. M., G. A. Brazeau, A. Keyhani, A. C. Hayman, and G. Lopez-Berestein. 1993. Role of liposome composition and temperature on the distribution of amphotericin B in serum lipoproteins. Antimicrob. Agents Chemother. 37:246-250.
    • (1993) Antimicrob. Agents Chemother. , vol.37 , pp. 246-250
    • Wasan, K.M.1    Brazeau, G.A.2    Keyhani, A.3    Hayman, A.C.4    Lopez-Berestein, G.5
  • 25
    • 9444240040 scopus 로고    scopus 로고
    • Enhanced amphotericin B nephrotoxicity in intensive care patients with elevated low-density cholesterol
    • in press
    • Wasan, K. M., and J. S. Conklin. Enhanced amphotericin B nephrotoxicity in intensive care patients with elevated low-density cholesterol. Clin. Infect. Dis., in press.
    • Clin. Infect. Dis.
    • Wasan, K.M.1    Conklin, J.S.2
  • 26
    • 0028136814 scopus 로고
    • Concentrations in serum and distribution in tissue of free and liposomal amphotericin B in rats during continuous intralipid infusion
    • Wasan, K. M., V. B. Grossie, Jr., and G. Lopez-Berestein. 1994. Concentrations in serum and distribution in tissue of free and liposomal amphotericin B in rats during continuous intralipid infusion. Antimicrob. Agents Chemother. 38:2224-2226.
    • (1994) Antimicrob. Agents Chemother. , vol.38 , pp. 2224-2226
    • Wasan, K.M.1    Grossie Jr., V.B.2    Lopez-Berestein, G.3
  • 27
    • 0027742038 scopus 로고
    • The influence of serum lipoproteins on the pharmacokinetics and pharmacodynamics of lipophilic drugs and drug carriers
    • Wasan, K. M., and G. Lopez-Berestein. 1993. The influence of serum lipoproteins on the pharmacokinetics and pharmacodynamics of lipophilic drugs and drug carriers. Arch. Med. Res. 24:395-401.
    • (1993) Arch. Med. Res. , vol.24 , pp. 395-401
    • Wasan, K.M.1    Lopez-Berestein, G.2
  • 28
    • 0028306292 scopus 로고
    • Decreased toxicity of liposomal amphotericin B due to association of amphotericin B with high-density lipoproteins: Role of lipid transfer protein
    • Wasan, K. M., R. E. Morton, M. G. Rosenblum, and G. Lopez-Berestein. 1994. Decreased toxicity of liposomal amphotericin B due to association of amphotericin B with high-density lipoproteins: role of lipid transfer protein. J. Pharm. Sci. 83:1006-1010.
    • (1994) J. Pharm. Sci. , vol.83 , pp. 1006-1010
    • Wasan, K.M.1    Morton, R.E.2    Rosenblum, M.G.3    Lopez-Berestein, G.4
  • 29
    • 0028084861 scopus 로고
    • Influence of lipoproteins on renal cytotoxicity and antifungal activity of amphotericin B
    • Wasan, K. M., M. G. Rosenblum, L. Cheung, and G. Lopez-Berestein. 1994. Influence of lipoproteins on renal cytotoxicity and antifungal activity of amphotericin B. Antimicrob. Agents Chemother. 38:223-227.
    • (1994) Antimicrob. Agents Chemother. , vol.38 , pp. 223-227
    • Wasan, K.M.1    Rosenblum, M.G.2    Cheung, L.3    Lopez-Berestein, G.4
  • 30
    • 0025259879 scopus 로고
    • Pharmacokinetics, tissue distribution and toxicity of free and liposomal amphotericin B in a diabetic rat model
    • Wasan, K. M., K. Vadiei, G. Lopez-Berestein, and D. R. Luke, 1990. Pharmacokinetics, tissue distribution and toxicity of free and liposomal amphotericin B in a diabetic rat model. J. Infect. Dis. 161:562-566.
    • (1990) J. Infect. Dis. , vol.161 , pp. 562-566
    • Wasan, K.M.1    Vadiei, K.2    Lopez-Berestein, G.3    Luke, D.R.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.